Effectiveness and Safety of Combination of Amlodipine and Zofenopril in Hypertensive Patients Versus Each Monotherapy

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 277 participants.

Also called NCT05279807

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 277 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05279807
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Hungary (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05279807. Non-randomized; no masking; primary purpose treatment. Start 2021-10-15 (actual); primary completion 2022-04-28 (actual). Results posted on 2024-10-21.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effectiveness and Safety of Combination of Amlodipine and Zofenopril in Hypertensive Patients Versus Each Monotherapy
Acronym
Masolino
Condition
Hypertension
Intervention (Drug)
Zofenopril
Intervention (Drug)
Amlodipine
Lead sponsor
Menarini International Operations Luxembourg SA (class: industry)

Record details

Record id
cardio:ct-nct05279807
Content hash
acd1ebc202e09e7ee3bb91aa8db6c115524e4df6bcfd7b9cd30be7b896d52e5b